Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-01

FDA Approved: ZOLMITRIPTAN — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' original ANDA for zolmitriptan tablets, providing a generic option for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)